Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novo Integrated Sciences (NVOS)
NASDAQ:NVOS
RESEARCH TOOLSreports
Novo Integrated Sciences (NVOS) Stock Price & Analysis
228 Followers
NVOS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.42 - $5.38
Previous Close$0.69
Volume628.38K
Average Volume (3M)7.40M
Market Cap
$12.35M
Enterprise Value$13.75M
Total Cash (Recent Filing)$1.54M
Total Debt (Recent Filing)$3.24M
Price to Earnings (P/E)―
Beta0.07
Next Earnings
Dec 11, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.37
Shares Outstanding19,054,523
10 Day Avg. Volume2,081,402
30 Day Avg. Volume7,398,793
Standard Deviation0.56
R-Squared0.00764
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)48.19
Price to Sales (P/S)4.73
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit2.78
Enterprise Value/Ebitda-0.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Novo Integrated Sciences News
PremiumCompany Announcements
Novo Integrated Sciences Announces Major Funds Disbursement
PremiumCompany Announcements
Novo Integrated Sciences Secures Leadership Until 2025
PremiumCompany Announcements
Novo Integrated Sciences Secures $78 Million Funding via HSBC
PremiumCompany Announcements
Novo Integrated Sciences Doubles Stock Buyback Program
PremiumCompany Announcements
Novo Integrated Sciences Ventures into Global Protein Market
PremiumMarket News
3 Penny Stocks to Watch NowOwnership Overview
1.57%
Insiders
1.87% Mutual Funds
2.13% Other Institutional Investors
94.42% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
NVOS FAQ
What was Novo Integrated Sciences’s price range in the past 12 months?
Novo Integrated Sciences lowest stock price was $0.42 and its highest was $5.38 in the past 12 months.
What is Novo Integrated Sciences’s market cap?
Currently, no data Available
When is Novo Integrated Sciences’s upcoming earnings report date?
Novo Integrated Sciences’s upcoming earnings report date is Dec 11, 2024 which is in 139 days.
How were Novo Integrated Sciences’s earnings last quarter?
Novo Integrated Sciences released its earnings results on Jul 19, 2024. The company reported -$0.735 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.735.
Is Novo Integrated Sciences overvalued?
According to Wall Street analysts Novo Integrated Sciences’s price is currently Overvalued.
Does Novo Integrated Sciences pay dividends?
Novo Integrated Sciences does not currently pay dividends.
What is Novo Integrated Sciences’s EPS estimate?
Novo Integrated Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novo Integrated Sciences have?
Novo Integrated Sciences has 19,054,523 shares outstanding.
What happened to Novo Integrated Sciences’s price movement after its last earnings report?
Novo Integrated Sciences reported an EPS of -$0.735 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.515%.
Which hedge fund is a major shareholder of Novo Integrated Sciences?
Currently, no hedge funds are holding shares in NVOS
---
Novo Integrated Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NVOS Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.29%
12-Months-Change
Fundamentals
Return on Equity
-133.23%
Trailing 12-Months
Asset Growth
-1.17%
Trailing 12-Months
Company Description
Novo Integrated Sciences
Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.
---
Technical Analysis
---